People · Operator
Named in public records as an officer, director or promoter · active 2019–2025 · Biotechnology, Other Technology, AI / ML, Healthtech, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BigHat Biosciences, Inc. | — | Biotechnology | Series D+ | $148.2M | $2.6B | 2019 |
| Flywheel Exchange Inc. | — | Other Technology | Series C | $144.1M | $97.9M | 2021 |
| Cambium Biomaterials, Inc. | — | Other Technology | Series C | $119.7M | $580.1M | 2021 |
| Unlearn.ai, Inc. | — | AI / ML | Series C | $115.0M | $593.3M | 2024 |
| Tempero Bio, Inc. | — | Biotechnology | Series C | $77.0M | $605.1M | 2024 |
| Sirona Medical, Inc. | — | Healthtech | Series B | $53.0M | $638.3M | 2020 |
| Mantra Bio, Inc. | — | Biotech / Pharma | Series B | $30.1M | $1.1B | 2019 |
Francisco Gimenez at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Francisco Gimenez on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Andrew Perlman | 1 | 15 |
| Paul Meister | 1 | 12 |
| Troy D. Kopischke | 1 | 10 |
| Danny J. Cunagin | 1 | 10 |
| Paul Johnson | 1 | 10 |
| Vineeta Agarwala | 1 | 8 |
| Dylan Morris | 1 | 8 |
| William Blake | 1 | 5 |
| Eric Shiozaki | 1 | 4 |
| James Olson | 1 | 4 |
| Charles Fisher | 1 | 4 |
| Marijn Dekkers | 1 | 4 |
| Joseph Jimenez | 1 | 3 |
| Jim Olson | 1 | 3 |
| Theresa Tribble | 1 | 3 |
| John McGovern | 1 | 3 |
| Robert Chess | 1 | 3 |
| Aaron Smith | 1 | 3 |
| Colby Moosman | 1 | 2 |
| Mark J. Sylvester | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.